Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
1.890
+0.020 (1.07%)
At close: Nov 13, 2026, 4:00 PM EST
1.890
0.00 (0.00%)
After-hours: Nov 13, 2026, 6:39 PM EST
CDIO Market Cap
CDIO has a market cap or net worth of $5.59 million as of November 13, 2026. It is the 44,315th most valuable company in the world and the 5,859th biggest in the United States. Its market cap has decreased by 18.10% in one year.
Market Cap
5.59M
Enterprise Value
1.89M
1-Year Change
-18.10%
Global Rank
Country Rank
#5,859 United States
Category
ChartMarket Cap Chart
Since July 26, 2022, CDIO's market cap has decreased from $368.96M to $5.59M, a decrease of -98.48%. That is a compound annual growth rate of -62.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 5.59M | 13.03% |
| Dec 31, 2025 | 4.95M | -86.66% |
| Dec 31, 2024 | 37.08M | -27.41% |
| Dec 29, 2023 | 51.09M | 406.54% |
| Dec 30, 2022 | 10.09M | -97.27% |
| Jul 26, 2022 | 368.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alzamend Neuro | 6.18M |
| Lantern Pharma | 6.17M |
| Cerenome | 6.15M |
| Processa Pharmaceuticals | 6.10M |
| SeaStar Medical Holding | 6.00M |
| XTL Biopharmaceuticals | 5.42M |
| Acurx Pharmaceuticals | 5.32M |
| CNS Pharmaceuticals | 5.29M |